Human Reproduction Update, Vol.3, No.3 pp.255-266, 1997
© European Society of Human Reproduction and Embryology 1997; all rights reserved
The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome
0 Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, University of South Alabama, Mobile, AL, USA 1 The Egyptian IVF-ET Center, Cairo University,Cairo, Egypt 2 Centre for Reproductive Medicine, Az-VUB, Laabeeklaan, Brussels, Belgium 3 IVF-Infertility Unit, Zeifirn, Israel z Corresponding author at: Division of Reproductive Endocrinology, 307 University Bouleard, CC/CB 326, Mobile, AL 36688, USA
Abstract
Ovarian hyperstimulation syndrome (OHSS) is a dramatic complication of ovulation induction. In its most severe form, OHSS is characterized by massive cystic enlargement of the ovaries associated with third space fluid shift, resulting in the formation of ascites and pleural effusion. Ascites develops because of increased peritoneal capillary permeability. In this study we examined the role of vascular endothelial growth factor (VEGF) and interleukins in the pathogenesis of increased capillary permeability. VEGF is a member of the family of heparin binding proteins that act directly on endothelial cells to induce proliferation and angiogenesis. VEGF mRNA and protein are expressed by human ovarian granulosa and theca cells late in follicular development and subsequent to ovulation by granulosa and theca cells. Therefore, VEGF is ideally positioned to provoke the increased permeability of theca blood vessels that occurs shortly before ovulation. Hybridization studies in the rat and primate ovary have demonstrated VEGF mRNA expression predominantly after the luteinizing hormone (LH) surge known to be essential for OHSS. The gonadotrophin-releasing hormone antagonist results in a decreased mRNA expression, implying such expression is dependent on LH. The expression of VEGF mRNA has been recently shown to be enhanced by human chorionic gonadotrophin (HCG) in a dose- and time-dependent fashion. These studies confirm the timely association between VEGF and HCG that has been clinically known for many years to be integral in the development of OHSS. VEGF concentrations in serum, peritoneal fluid and follicular fluid of patients at risk for OHSS have been shown to be significantly related to the development of the syndrome. Furthermore, the kinetics of VEGF in the plasma of patients who actually develop severe OHSS are closely correlated with the clinical course of the syndrome and with certain biological characteristics of OHSS and of capillary leakage, such as leukocytosis and increased haematocrit. Studies on ascitic fluid from patients with severe OHSS have proved that VEGF is the major capillary permeability agent. Incubation with VEGF antiserum decreased the vascular permeability activity by 70%. Interleukin-2 (IL-2) is the first of a series of lymphocytotrophic hormones to be recognized as pivotal for the regulation of immune response. However, hard data to confirm its central role in the pathogenesis of OHSS are still lacking, despite the fact that some preliminary studies suggest a positive association between the pooled follicular fluid IL-2 concentration and the development of OHSS. IL-6 is a mediator of the acute phase response to injury, a systemic reaction characterized by leukocytosis, increased vascular permeability and increased synthesis of acute phase proteins by the liver. Significantly higher serum and ascites IL-6 concentrations were seen in OHSS patients. The immunohistochemical localization pattern suggested that IL-6 is LH or HCG dependent. However, the use of IL-6 as a predictor for the occurrence of OHSS has not been successful. The kinetics of IL-6 in patients with severe OHSS are correlated with the clinical symptoms and the biochemical parameters known to be associated with the severity of the syndrome, suggesting a possible role for IL-6. Further molecular biology studies similar to those performed on EGF are needed to confirm if this interleukin is central in the cascade of events. IL-8 is a chemoattractant, activating cytokine and a potent angiogenic agent. The peritoneal fluid levels is increased in patients with severe OHSS; its concentration in peritoneal fluid is increased in patients with severe OHSS. The place of this interleukin in the cascade of events is as yet undetermined and further studies are needed. In conclusion, molecular biology and clinical studies strongly suggest that VEGF is the principal mediator by which HCG might increase capillary permeability in OHSS.
Keywords: cytokines/interleukins/ovarian hyperstimulation syndrome/ovulation induction/vascular endothelial growth factor
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. R. Soares, R. Gomez, C. Simon, J. A. Garcia-Velasco, and A. Pellicer Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome Hum. Reprod. Update, April 2, 2008; (2008) dmn008v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kosaka, H. Fujiwara, S. Yoshioka, and S. Fujii Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome Hum. Reprod., June 1, 2007; 22(6): 1647 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. U. Gurkan, C. O'Donnell, R. Brower, E. Ruckdeschel, and P. M. Becker Differential effects of mechanical ventilatory strategy on lung injury and systemic organ inflammation in mice Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L710 - L718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Islami, P. Bischof, and D. Chardonnens Modulation of placental vascular endothelial growth factor by leptin and hCG Mol. Hum. Reprod., July 1, 2003; 9(7): 395 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. SASSON, A. DANTES, K. TAJIMA, and A. AMSTERDAM Novel genes modulated by FSH in normal and immortalized FSH-responsive cells: new insights into the mechanism of FSH action FASEB J, July 1, 2003; 17(10): 1256 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.O. Amarin Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome: An aggressive, but perhaps life-saving procedure Hum. Reprod., April 1, 2003; 18(4): 659 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gomez, C. Simon, J. Remohi, and A. Pellicer Vascular Endothelial Growth Factor Receptor-2 Activation Induces Vascular Permeability in Hyperstimulated Rats, and this Effect Is Prevented by Receptor Blockade Endocrinology, November 1, 2002; 143(11): 4339 - 4348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-A. Pan, M.-H. Wu, Y.-C. Cheng, C.-H. Li, and F.-M. Chang Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis Hum. Reprod., January 1, 2002; 17(1): 201 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Quintana, L. Kopcow, G. Marconi, C. Sueldo, G. Speranza, and R.I. Baranao Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis Hum. Reprod., September 1, 2001; 16(9): 1814 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.L. Benifla, A.F. Bringuier, C. Sifer, R. Porcher, P. Madelenat, and G. Feldmann Vascular endothelial growth factor, platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 in the follicular fluid of patients undergoing IVF Hum. Reprod., July 1, 2001; 16(7): 1376 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-H. Chen, C.-C. Wu, S. Roy, S.-M. Lee, and J.-H. Liu Increased Interleukin-6 in Aqueous Humor of Neovascular Glaucoma Invest. Ophthalmol. Vis. Sci., October 1, 1999; 40(11): 2627 - 2632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ludwig, W. Jelkmann, O. Bauer, and K. Diedrich Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration Hum. Reprod., October 1, 1999; 14(10): 2437 - 2441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Todros, C.M. Carmazzi, S. Bontempo, P. Gaglioti, V. Donvito, and M. Massobrio Spontaneous ovarian hyperstimulation syndrome and deep vein thrombosis in pregnancy: Case report Hum. Reprod., September 1, 1999; 14(9): 2245 - 2248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Poliakova, I. Kovesdi, X. Wang, M. C. Capogrossi, and M. Talan VASCULAR PERMEABILITY EFFECT OF ADENOVIRUS-MEDIATED VASCULAR ENDOTHELIAL GROWTH FACTOR GENE TRANSFER TO THE RABBIT AND RAT SKELETAL MUSCLE J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 339 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Doldi, A. Destefani, A. Gessi, D. Grossi, and A. Ferrari Human albumin enhances expression of vascular endothelial growth factor in cultured human luteinizing granulosa cells: importance in ovarian hyperstimulation syndrome Hum. Reprod., May 1, 1999; 14(5): 1157 - 1159. [Abstract] [Full Text] [PDF]
|
|